FDA Accepts Galderma’s BLA Resubmission for RelabotulinumtoxinA
The agency has accepted the resubmission seeking approval of the neuromodulator for the temporary improvement of moderate-to-severe glabellar lines and crow’s feet in adults.
The agency has accepted the resubmission seeking approval of the neuromodulator for the temporary improvement of moderate-to-severe glabellar lines and crow’s feet in adults.
A multicenter, blinded study adds clinical evidence for ultrasound as a noninvasive approach to improving cellulite and skin laxity.
Nine e-posters showcase efficacy and safety data for botulinum neurotoxin serotype E and onabotulinumtoxinA treatments.
As GLP-1s grow in popularity, more Americans are rethinking weight loss in the new year.
rater8 has introduced AI Insights, a conversational AI feature within its raVE platform that allows healthcare practices to query and quickly extract actionable answers from their patient feedback data.